This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain.
The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects
credit:
to the point where they meet the entry criteria for the Pain Therapeutics Development Program.
The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).